Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Organic Letters|April 19, 2013
Synthesis of intervenolin, an antitumor natural quinolone with unusual substituentsHikaru Abe, Manabu Kawada, Hiroyuki Inoue, et al.
The Journal of Antibiotics|July 29, 2021
Androprostamine A: a unique antiprostate cancer agentYohko Yamazaki, Hikaru Abe, Chiharu Sakashita, et al.
The Journal of Antibiotics|October 12, 2017
Biological activity of intervenolin analogs with a phenyl substituentHikaru Abe, Manabu Kawada, Masayuki Igarashi, et al.
Bioorganic & Medicinal Chemistry Letters|March 25, 2009
Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitorsTakumi Watanabe, Isao Momose, Masatoshi Abe, et al.
Cancer Science|September 25, 2014
Antitumor effects of tyropeptin-boronic acid derivatives: New proteasome inhibitorsIsao Momose, Hikaru Abe, Takumi Watanabe, et al.
International Journal of Cancer|March 8, 2020
Inhibition of mitochondria ATP synthase suppresses prostate cancer growth through reduced insulin-like growth factor-1 secretion by prostate stromal cellsTomokazu Ohishi, Hikaru Abe, Chiharu Sakashita, et al.
The Journal of Antibiotics|April 10, 2010
NBRI17671, a new antitumor compound, produced by Acremonium sp. CR17671Manabu Kawada, Ihomi Usami, Tetsuya Someno, et al.
Cancer Science|January 9, 2026
SUSD2 Promotes Metastasis and Primary Tumor Growth in Pancreatic Cancer Cells via Integrin-FAK Signaling ActivationJunjiro Yoshida, Tomokazu Ohishi, Isao Momose, et al.
Plos One|March 19, 2015
Stromal cells positively and negatively modulate the growth of cancer cells: stimulation via the PGE2-TNFα-IL-6 pathway and inhibition via secreted GAPDH-E-cadherin interactionManabu Kawada, Hiroyuki Inoue, Shun-ichi Ohba, et al.
The Journal of Antibiotics|May 2, 2013
Intervenolin, a new antitumor compound with anti-Helicobacter pylori activity, from Nocardia sp. ML96-86F2Manabu Kawada, Hiroyuki Inoue, Shun-Ichi Ohba, et al.
Pageof 3